Stock Research: UCB

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

UCB

ENXTBR:UCB BE0003739530
65
  • Value
    22
  • Growth
    93
  • Safety
    Safety
    31
  • Combined
    47
  • Sentiment
    90
  • 360° View
    360° View
    65
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

UCB SA is a biopharmaceutical and specialty chemical company specializing in central nervous system (CNS) and immunology diseases. Its main business includes CNS disorders like epilepsy and immunology disorders such as rheumatoid arthritis. UCB SA operates globally, with a focus on Europe and North America. In the last fiscal year, the company had a market cap of $39,605 million, profits of $4,555 million, revenue of $6,369 million, and 9378 employees.

more
Index
BEL20
Human Rights
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
22 6 79 74
Growth
93 90 89 19
Safety
Safety
31 24 24 38
Sentiment
90 61 10 38
360° View
360° View
65 37 45 30
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
55 49 36 49
Opinions Change
73 59 24 48
Pro Holdings
n/a 45 14 56
Market Pulse
81 69 47 27
Sentiment
90 61 10 38
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
22 6 79 74
Growth
93 90 89 19
Safety Safety
31 24 24 38
Combined
47 24 82 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
26 15 54 71
Price vs. Earnings (P/E)
17 11 46 54
Price vs. Book (P/B)
28 21 81 78
Dividend Yield
32 32 70 65
Value
22 6 79 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
83 94 54 6
Profit Growth
92 54 77 48
Capital Growth
88 56 76 21
Stock Returns
59 96 52 54
Growth
93 90 89 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
60 61 48 43
Refinancing
21 18 23 24
Liquidity
25 31 40 56
Safety Safety
31 24 24 38

Similar Stocks

Discover high‑ranked alternatives to UCB and broaden your portfolio horizons.

BMW

XTRA:BMW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Repsol

BME:REP
Country: Spain
Industry: Oil & Gas Integrated
Size: X-Large
Full Stock Analysis

Tessenderlo

ENXTBR:TESB
Country: Belgium
Industry: Diversified Chemicals
Size: Medium
Full Stock Analysis

Krka

LJSE:KRKG
Country: Slovenia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: